Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].
about
Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infectionWhat are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi processEffects of long-term PPI treatment on producing bowel symptoms and SIBO.Food allergy: only a pediatric disease?Proton pump inhibitor use before percutaneous endoscopic gastrostomy is associated with adverse outcomes.Variables Associated with Adherence to Stress Ulcer Prophylaxis in Patients Admitted to the General Hospital Wards: A Prospective Study.Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascitesProton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implicationsOne fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable.Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesiumAssociation between proton pump inhibitor use and anemia: a retrospective cohort study.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.The impact of proton pump inhibitors on the human gastrointestinal microbiomeUse of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based StudyUse of proton pump inhibitors is associated with fractures in young adults: a population-based study.Indication of acid suppression therapy and predictors for the prophylactic use of protonpump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital.Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.Association of Proton Pump Inhibitor (PPI) Use with Energy Intake, Physical Activity, and Weight Gain.Many patients continue using proton pump inhibitors after negative results from tests for reflux diseaseAntagonism of Fluconazole and a Proton Pump Inhibitor against Candida albicans.Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients.Gastroesophageal reflux disease after diagnostic endoscopy in the clinical setting.Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease.Attitude and Knowledge of Indian Emergency Care Residents towards Use of Proton Pump Inhibitors.Orders for intravenous proton pump inhibitors after implementation of an electronic alert.The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.Non-Specific Gastric Inflammation in Children is Associated with Proton Pump Inhibitor Treatment for More than 6 Weeks.Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials.Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications.Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole.Esophageal reflux disease proton pump inhibitor therapy impact on sleep disturbance: a systematic review.The risks of PPI therapy.Stress prophylaxis in intensive care unit patients and the role of enteral nutrition.HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis.Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors.
P2860
Q26849521-DEA2E067-8457-4C79-B7D3-0905AD5444F8Q28545785-A443C4BF-378E-435A-8483-05B933DB4ACCQ33448825-E21AFE1E-7A76-497C-AF0D-D68CC85093C1Q33619973-60162578-D599-4158-B013-ECECEF83956AQ33633645-64414B15-099A-43C0-9B9B-610F5F1DCC84Q33664102-A58A05D6-123B-4D44-8C10-7892B6ACDF65Q33675495-58B0794A-F807-4805-996A-9EF0A4BD036AQ33811004-3589A40D-2E5B-454D-8D8A-B19010BE8D11Q33949498-1EB01146-6D91-4E03-B799-4BB8ECC8BDA0Q34036732-D05F2FAA-BCF3-4E7B-8FD0-D093B540DEADQ34140914-DF6EC6C6-39CC-4B8C-8AA1-7A4699A68D6BQ34164370-D90A6257-973C-4B03-B2FA-595801FAC991Q34479280-083FF5FF-F52F-4EC2-AC41-C33BC3A51F1EQ34625008-2A563704-B2A9-4F01-8A82-56664A4A547BQ35999704-5760BFB3-4959-4CE9-A31D-F1564CA15854Q36075131-EC613A18-65C7-40BD-A545-3D96C8C609CAQ36092263-CC7DF227-177E-40A6-BA7A-7F9DD92EC26EQ36145570-F0CDBE25-FAC4-444D-BB37-48185EC68436Q36246777-A97EAE81-D5CF-461D-9E06-F38B652B247BQ36540981-C803B05C-DB5B-4713-A198-94F015F19829Q36571941-2D0B0FA4-6D5E-4197-9C3D-D4B6038DAA2FQ36717591-F2A67086-E962-48FD-BF39-B481657958BCQ36821636-025EE984-2D34-441C-9714-05115EFD61C6Q36822474-A7513BAD-7762-42D2-8E7E-3187BB9B9FBEQ36927372-482D9034-7621-4908-B404-00126C658D03Q36979081-F6F487C6-019D-4F99-B368-D7787B2AC4BFQ37255233-A8782071-EFB3-459E-AE08-F10E6DF72E62Q37395858-E35B2A82-EF10-40A2-9D83-3D336BBA8241Q37494172-2C0FBC1D-F8A5-474C-9E7D-8F9B30DF3B0DQ37658639-734D0B0A-75E0-4929-A103-85569E314286Q37663683-90621F0D-381E-4FBA-A170-5DEF090D9CC7Q37671220-667A08F9-F261-4C00-9CDB-66EB4345FDDCQ37718284-5A398552-A89B-4D31-AA09-F2C7F4CD48C8Q37808356-DF2C3F5C-7052-43ED-86DE-30CDC96E8269Q37981611-F7E67D4E-5226-4E41-82AB-7618B158F31CQ37983706-53B0C732-6692-4961-9FCB-0045768B683AQ37993057-8C083099-B836-4C99-B8D5-2475B7DD06B1Q38030483-0A006264-9CFD-404F-8E6A-539BA10DA0F8Q38219502-1D3C9AD8-3CC3-47D8-8120-A7ACE4705512Q38406515-0BE938C7-6C49-4215-9F12-BF6A63145FB8
P2860
Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Overutilization of proton pump ...... tiveness and risk [corrected].
@en
Overutilization of proton pump ...... tiveness and risk [corrected].
@nl
type
label
Overutilization of proton pump ...... tiveness and risk [corrected].
@en
Overutilization of proton pump ...... tiveness and risk [corrected].
@nl
prefLabel
Overutilization of proton pump ...... tiveness and risk [corrected].
@en
Overutilization of proton pump ...... tiveness and risk [corrected].
@nl
P2860
P356
P1476
Overutilization of proton pump ...... tiveness and risk [corrected].
@en
P2093
Joel J Heidelbaugh
Kathleen L Goldberg
P2860
P304
P356
10.1038/AJG.2009.49
P407
P478
104 Suppl 2
P50
P577
2009-03-01T00:00:00Z